Secure Fast Turkish HTA Market Entry and Approval
Navigating complex Turkish regulatory landscapes requires more than just words; you need scientific precision to ensure your HTA submissions resonate with local authorities
Request an HTA Translation Quote Today
Are Linguistic Errors in Your Turkish HTA Dossier Risking Costly Regulatory Delays and Market Rejection?
Regulatory bodies demand absolute precision in HTA documentation to ensure patient safety and economic viability
Regulatory Rejection
Poorly translated clinical endpoints often lead to immediate dossier rejection by Turkish health authorities and SGK committees
Launch Delays
Every week of market access delay due to linguistic revisions costs pharmaceutical companies millions in potential revenue
Economic Misalignment
Inaccurate pharmacoeconomic terminology can misrepresent cost-effectiveness models, resulting in unfavorable reimbursement decisions
Why Turklingua is the Gold Standard for HTA
Decades of trust from the world's leading life science innovators
Turklingua has spent over 30 years perfecting the art of medical and regulatory translation. We don't just translate; we transcreate scientific value into the Turkish language context with unmatched authority.
Our secure infrastructure protects your highly confidential HTA data, ensuring that sensitive clinical results and pricing strategies remain protected throughout the entire translation lifecycle.
With a proven track record of successful Turkish market entries, we provide the linguistic reliability needed to satisfy the most stringent regulatory audits and health committee reviews.
Mastery in Turkish HTA and Pharmacoeconomics
Our linguistic team consists of MDs and PhDs who understand the Turkish regulatory heartbeat
Mastering the Turkish HTA landscape involves more than just translating text; it requires a deep dive into pharmacoeconomic modeling and local reimbursement criteria. Our expert linguists bridge the gap between global clinical data and Turkish regulatory expectations, ensuring every nuance of your submission is preserved and perfectly articulated for reviewers.
We strictly adhere to ISO 17100 standards, employing a multi-layered review process that includes subject-matter expert (SME) verification. This ensures that technical terms like Quality-Adjusted Life Years (QALY) or Incremental Cost-Effectiveness Ratio (ICER) are translated with 100% terminological accuracy for the Turkish Social Security Institution.
Our three decades of experience allow us to anticipate the linguistic preferences of Turkish evaluators. By choosing Turklingua, you are not just getting a translation; you are securing a strategic linguistic partner that understands the socio-economic context of the Turkish healthcare system and its unique HTA requirements.
Our Precision HTA Translation Protocol
A meticulous six-step process designed for zero-error regulatory submissions
Project Scoping and Glossary
We begin by defining the project scope and developing a customized Turkish glossary of HTA terms to ensure consistency across all dossier components.
SME-Led Translation
Your documents are translated by medical professionals who possess deep expertise in pharmacoeconomics and Turkish health regulations.
Bilingual Comparative Review
A second senior linguist performs a bilingual check to ensure source-to-target accuracy and proper transfer of scientific meaning.
Technical QA and Formatting
We conduct rigorous QA on all data tables, graphs, and mathematical models to ensure that visual evidence remains intact and localized.
Regulatory Alignment Audit
The final text is audited for TITCK compliance, ensuring that all stylistic conventions meet the exact requirements of Turkish health authorities.
Final Certification and Delivery
We provide a Certificate of Accuracy and deliver your submission-ready files, ready for immediate filing with the relevant Turkish agencies.
Expert answers to your most critical regulatory translation questions
Strategic Clarifications on Turkish HTA Services
How do you ensure the accuracy of complex pharmacoeconomic models?
We utilize specialized medical linguists who understand both the mathematical logic and the linguistic nuances of HTA. Our process involves a side-by-side verification of all data points in cost-effectiveness and budget impact models to ensure the Turkish version is an identical functional equivalent of the original.
Is your translation process compliant with Turkish regulatory standards?
Yes, our workflow is fully aligned with ISO 17100:2015 and TITCK guidelines. We maintain a deep understanding of the Turkish Medicines and Medical Devices Agency's specific terminology requirements, ensuring that your submission meets all local regulatory expectations from the first draft.
Can you handle urgent deadlines for HTA submission responses?
We are built for high-pressure regulatory cycles. Our team can scale rapidly to handle large dossiers or urgent Request for Information (RFI) responses from Turkish authorities, maintaining absolute precision even under the tightest market access timelines.
How do you protect the confidentiality of sensitive clinical data?
Confidentiality is our highest priority. We use enterprise-grade encryption and strict Non-Disclosure Agreements (NDAs) for all personnel. Your intellectual property and proprietary clinical findings are handled within a secure, closed-loop environment throughout the translation process.
Do you translate patient-reported outcomes (PROs) and quality-of-life scales?
Absolutely. Translating PROs requires linguistic validation and cultural adaptation. We ensure that these instruments are not only accurately translated but also culturally resonant for Turkish patients, maintaining the psychometric integrity of the original scales.
Which HTA software and formats do you support?
We support all standard formats, including complex Excel models, XML-based regulatory filings, and specialized pharmacoeconomic software outputs. Our team ensures that formatting and formulas remain functional after the Turkish localization process is complete.
Why is expert translation critical for the Turkish Social Security Institution (SGK)?
The SGK reimbursement committees rely on absolute clarity to make funding decisions. Any ambiguity in the clinical evidence or economic benefit can lead to unfavorable pricing. Our translations eliminate linguistic risk, presenting your value proposition in the most authoritative Turkish possible.
What sets Turklingua apart from general translation agencies in HTA?
General agencies lack the scientific depth required for HTA. Turklingua offers three decades of specialization in the Turkish market. We provide expert-level medical SMEs who understand health economics, ensuring your submission is scientifically sound and regulatory-ready.
Trusted by Global Life Science Leaders
Our work has supported dozens of successful Turkish market launches
Turklingua’s precision in translating our HTA value dossiers was instrumental in our successful Turkish reimbursement negotiation last year.
Director of Regulatory Affairs
Pharmaceuticals
Basel, Switzerland
The technical accuracy of their Turkish pharmacoeconomic modeling translation is simply unparalleled in the industry. A true partner.
Market Access Manager
Biotechnology
Cambridge, MA, USA
When facing tight regulatory deadlines, Turklingua delivered flawless Turkish submissions that passed TITCK scrutiny without a single linguistic query.
Head of Clinical Operations
Medical Devices
Reading, UK
Global Pharmaceutical and Med-Tech Partners
Further Exploration
Related Industry Sectors
Related Document Types